EP3963064A1 - Verbesserte reinigungsleistung gegenüber protein-empfindlichen anschmutzungen vi - Google Patents
Verbesserte reinigungsleistung gegenüber protein-empfindlichen anschmutzungen viInfo
- Publication number
- EP3963064A1 EP3963064A1 EP20719389.7A EP20719389A EP3963064A1 EP 3963064 A1 EP3963064 A1 EP 3963064A1 EP 20719389 A EP20719389 A EP 20719389A EP 3963064 A1 EP3963064 A1 EP 3963064A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- amino acid
- protease
- positions
- acid substitution
- position corresponding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004140 cleaning Methods 0.000 title claims abstract description 34
- 108090000623 proteins and genes Proteins 0.000 title claims description 57
- 102000004169 proteins and genes Human genes 0.000 title claims description 55
- 108091005804 Peptidases Proteins 0.000 claims abstract description 194
- 239000004365 Protease Substances 0.000 claims abstract description 194
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 123
- 238000006467 substitution reaction Methods 0.000 claims abstract description 99
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 50
- 150000001413 amino acids Chemical class 0.000 claims description 41
- 150000007523 nucleic acids Chemical class 0.000 claims description 38
- 238000005406 washing Methods 0.000 claims description 36
- 108020004707 nucleic acids Proteins 0.000 claims description 34
- 102000039446 nucleic acids Human genes 0.000 claims description 34
- 239000012459 cleaning agent Substances 0.000 claims description 30
- 239000013598 vector Substances 0.000 claims description 16
- 239000004753 textile Substances 0.000 claims description 13
- 238000012217 deletion Methods 0.000 claims description 9
- 230000037430 deletion Effects 0.000 claims description 9
- 238000003780 insertion Methods 0.000 claims description 9
- 230000037431 insertion Effects 0.000 claims description 9
- 238000002703 mutagenesis Methods 0.000 claims description 8
- 231100000350 mutagenesis Toxicity 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 239000013604 expression vector Substances 0.000 claims description 6
- 238000013467 fragmentation Methods 0.000 claims description 5
- 238000006062 fragmentation reaction Methods 0.000 claims description 5
- 239000013599 cloning vector Substances 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 18
- 102000035195 Peptidases Human genes 0.000 abstract description 176
- 235000019419 proteases Nutrition 0.000 description 126
- 102000004190 Enzymes Human genes 0.000 description 58
- 108090000790 Enzymes Proteins 0.000 description 58
- 229940088598 enzyme Drugs 0.000 description 58
- 210000004027 cell Anatomy 0.000 description 54
- 235000018102 proteins Nutrition 0.000 description 49
- 239000003599 detergent Substances 0.000 description 35
- 230000000694 effects Effects 0.000 description 22
- 230000008569 process Effects 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000000126 substance Substances 0.000 description 14
- 238000000855 fermentation Methods 0.000 description 13
- 230000004151 fermentation Effects 0.000 description 13
- 239000007788 liquid Substances 0.000 description 13
- 241000194103 Bacillus pumilus Species 0.000 description 12
- 230000002255 enzymatic effect Effects 0.000 description 12
- 239000002609 medium Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 238000003860 storage Methods 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 108020004705 Codon Proteins 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 230000035772 mutation Effects 0.000 description 8
- 241000193830 Bacillus <bacterium> Species 0.000 description 7
- 125000000539 amino acid group Chemical group 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000002797 proteolythic effect Effects 0.000 description 7
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 108090000787 Subtilisin Proteins 0.000 description 5
- 101710135785 Subtilisin-like protease Proteins 0.000 description 5
- 108010056079 Subtilisins Proteins 0.000 description 5
- 102000005158 Subtilisins Human genes 0.000 description 5
- 239000012190 activator Substances 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- -1 subtilopeptidases Proteins 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000001212 derivatisation Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000003527 eukaryotic cell Anatomy 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 238000011105 stabilization Methods 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 241000193422 Bacillus lentus Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 108700010070 Codon Usage Proteins 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000004851 dishwashing Methods 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 102100032487 Beta-mannosidase Human genes 0.000 description 2
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 2
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 108010059820 Polygalacturonase Proteins 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 108010055059 beta-Mannosidase Proteins 0.000 description 2
- AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 210000003855 cell nucleus Anatomy 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000002887 multiple sequence alignment Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 210000001322 periplasm Anatomy 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- 241000203809 Actinomycetales Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193375 Bacillus alcalophilus Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241001328119 Bacillus gibsonii Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241000235649 Kluyveromyces Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108091092724 Noncoding DNA Proteins 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 102100038946 Proprotein convertase subtilisin/kexin type 6 Human genes 0.000 description 1
- 241000185994 Pseudarthrobacter oxydans Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000588746 Raoultella planticola Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000122971 Stenotrophomonas Species 0.000 description 1
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187432 Streptomyces coelicolor Species 0.000 description 1
- 241000187398 Streptomyces lividans Species 0.000 description 1
- 108700037663 Subtilisin-like proteases Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 108010047754 beta-Glucosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 102220405922 c.244C>T Human genes 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940066758 endopeptidases Drugs 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000002979 fabric softener Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 150000002256 galaktoses Chemical class 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000013038 irreversible inhibitor Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 108020001775 protein parts Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000009991 scouring Methods 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 108010038851 tannase Proteins 0.000 description 1
- 108010031354 thermitase Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 108010083879 xyloglucan endo(1-4)-beta-D-glucanase Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21062—Subtilisin (3.4.21.62)
Definitions
- the invention is in the field of enzyme technology.
- the invention relates to proteases from Bacillus pumilus, the amino acid sequence of which has been changed, in particular with regard to use in detergents and cleaning agents, in order to give them better cleaning performance, and the nucleic acids coding for them and their production.
- the invention also relates to the uses of these proteases and processes in which they are used, as well as agents containing them, in particular washing and cleaning agents.
- proteases are among the technically most important enzymes of all. They are the longest established enzymes for laundry detergents and cleaning agents and are contained in practically all modern, high-performance laundry detergents and cleaning agents. They cause the degradation of protein-containing soiling on the items to be cleaned.
- proteases of the subtilisin type (subtilases, subtilopeptidases, EC 3.4.21.62) are particularly important, which are serine proteases due to the catalytically active amino acids. They act as non-specific endopeptidases and hydrolyze any acid amide bonds that are inside peptides or proteins. Their pH optimum is usually in the clearly alkaline range.
- Subtilases Subtilisin-like Proteases
- R. Siezen pages 75-95 in “Subtilisin enzymes”, edited by R. Bott and C. Betzel, New York, 1996.
- Subtilases are natural formed by microorganisms. Among these, the subtilisins formed and secreted by Bacillus species should be mentioned as the most important group within the subtilases.
- proteases of the subtilisin type preferably used in detergents and cleaning agents are the subtilisins BPN 'and Carlsberg, the protease PB92, the subtilisins 147 and 309, the protease from Bacillus lentus, in particular from Bacillus lentus DSM 5483, subtilisin DY and the the subtilases, but no longer the subtilisins in the narrower sense, the enzymes thermitase, proteinase K and the proteases TW3 and TW7, as well as variants of the proteases mentioned, which have a changed amino acid sequence compared to the starting protease.
- Proteases are modified in a targeted or random manner by methods known from the prior art and thus optimized for use in detergents and cleaning agents, for example. These include point mutagenesis, deletion or insertion mutagenesis or fusion with other proteins or protein parts. For most of the proteases known from the prior art, correspondingly optimized variants are known.
- protease from Bacillus pumilus intended for detergents and cleaning agents is disclosed.
- only selected proteases are suitable for use in liquid surfactant-containing preparations.
- Many proteases do not show sufficient catalytic properties in such preparations Power.
- a high catalytic activity under conditions such as those presented during a wash cycle and a high storage stability are particularly desirable.
- liquid formulations containing proteases and surfactants from the prior art have the disadvantage that the proteases contained do not have a satisfactory proteolytic activity or are not storage-stable under standard washing conditions (for example in a temperature range from 20 ° C. to 40 ° C.) the formulations therefore do not show optimal cleaning performance on protease-sensitive soils.
- protease from Bacillus pumilus or a protease that is sufficiently similar to this which based on the numbering according to SEQ ID NO: 1 at the positions corresponding to positions 9, 133, 144, 252 and 271, which have amino acid substitutions selected from 9T, 133A, 144K, 252T and 271 E, and at least one further amino acid substitution in at least one of the positions corresponding to positions 3, 4, 82, 156, 162 and 218, with regard to cleaning performance on protein-sensitive soiling is improved compared to the wild-type form and / or the reference mutant and is therefore particularly suitable for use in detergents or cleaning agents.
- the invention therefore relates to a protease comprising an amino acid sequence which has at least 70% sequence identity with the amino acid sequence indicated in SEQ ID NO: 1 over its entire length and in each case based on the numbering according to SEQ ID NO: 1:
- (i) has amino acid substitutions at positions corresponding to positions 9, 133, 144, 252 and 271, preferably selected from amino acid substitutions 9T, 133A, 144K, 252T and 271 E;
- (ii) has at least one further amino acid substitution in at least one of the positions corresponding to positions 3, 4, 82, 156, 162 and 218.
- the invention also relates to a protease comprising an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 over its entire length and in each case based on the numbering according to SEQ ID NO: 1
- (A) has at least one amino acid substitution in at least one of the positions which correspond to positions 3, 4 and 218, preferably selected from 3K, 3A, 3R, 3S, 4A, 4I, 4T and 218S and / or
- the invention also relates to a method for producing a protease as defined above, comprising the substitution of amino acids in a starting protease which has at least 70% sequence identity to the amino acid sequence given in SEQ ID NO: 1 over its entire length (i) at the positions which correspond to positions 9, 133, 144, 252 and 271 in SEQ ID NO: 1, in such a way that the protease at the positions comprises amino acid substitutions, in particular the amino acid substitutions selected from 9T, 133A, 144K, 252T and 271 E; and (ii) has at least one further amino acid substitution in at least one of the positions corresponding to positions 3, 4, 82, 156, 162 and 218.
- the protease obtainable by means of this method has at least 70% sequence identity to the amino acid sequence given in SEQ ID NO: 1 over its entire length.
- a protease within the meaning of the present patent application therefore comprises both the protease as such and a protease produced using a method according to the invention. All statements about the protease therefore relate both to the protease as such and to the proteases produced by means of corresponding processes.
- nucleic acids coding for these proteases relate to the nucleic acids coding for these proteases, proteases according to the invention or non-human host cells containing nucleic acids and agents comprising proteases according to the invention, in particular detergents and cleaning agents, washing and cleaning methods, and uses of the proteases according to the invention in washing or cleaning agents for removing protein-containing soiling.
- At least one means one or more, i. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1, 12, 13, 14 or more.
- the present invention is based on the surprising finding of the inventors that amino acid substitutions at the positions described herein bring about an improved cleaning performance of this modified protease in detergents and cleaning agents.
- a protease according to the invention is characterized in that it comprises an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 over its entire length and in each case, based on the numbering according to SEQ ID NO: 1, has:
- amino acid substitutions preferably selected from amino acid substitutions 9T, 133A, 144K, 252T and 271 E;
- a protease as described herein additionally has an additional amino acid substitution at the position corresponding to position 130. In various embodiments, this additional amino acid substitution is 130D.
- a protease according to the invention is characterized in that it comprises an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 over its entire length and in each case based on the numbering according to SEQ ID NO: 1
- (A) has at least one amino acid substitution in at least one of the positions which correspond to positions 3, 4 and 218, preferably selected from 3K, 3A, 3R, 3S, 4A, 4I, 4T and 218S and / or
- (B) has at least one amino acid substitution selected from 156D and 1621 in at least one of positions corresponding to positions 156 and 162.
- the protease consequently has amino acid substitutions at the positions corresponding to positions 9, 133, 144, 252 and 271, preferably selected from 9T, 133A, 144K, 252T and 271 E, and additionally at the positions corresponding to Positions 3, 4, 9, 82, 156, 162 and 218 correspond to at least one, ie for example 1, 2, 3, 4, 5 or 6 amino acid substitution (s) selected from: 3K, 3A, 3R, 3S, 4A, 4I, 4T, 9T, 82F, 156D and 1621 and 218S.
- a protease according to the invention is characterized in that
- amino acid substitution at the position corresponding to position 3 is selected from 3K, 3A, 3R and 3S; and or
- amino acid substitution at the position corresponding to position 4 is selected from 4A, 4I and 4T; or
- amino acid substitution at the position corresponding to position 162 is selected from 1621;
- a protease according to the invention is characterized in that a) the amino acid substitution at the position corresponding to position 3 is selected from 3K, 3A and 3S; and or b) the amino acid substitution at the position corresponding to position 4 is selected from 4A, 41 and 4T; or
- a protease according to the invention is characterized in that the amino acid substitution at the position corresponding to position 3 is selected from 3K and the amino acid substitution at the position corresponding to position 4 is selected from 41.
- has the protease according to the invention has substitutions at positions 3 and 4, these being preferably selected from those mentioned herein, preferably (i) 3K and 41, (ii) 3A and 41 or (iii) 3A and 4A.
- the protease has amino acid substitutions, especially those at positions corresponding to positions 9, 133, 144, 252 and 271
- a protease according to the invention additionally has an additional amino acid substitution at the position corresponding to position 130, this preferably being 130D.
- Such proteases are disclosed, for example, as mutants 2-10 in the examples and are thus the subject of the invention.
- the proteases according to the invention have an improved cleaning performance.
- the proteases according to the invention can have a proteolytic activity which, based on the wild type (SEQ ID NO: 1), is at least 101%, preferably at least 102% or more.
- Such performance-enhanced proteases enable improved washing results on proteolytically sensitive soiling in different temperature ranges, in particular a temperature range from 20 ° C to 40 ° C.
- the proteases according to the invention can have an increased storage stability in detergents or cleaning agents independently of or in addition to the increased cleaning performance. This means that in comparison to the reference enzyme (according to SEQ ID NO: 1) and in particular also compared to the starting variant of the protease (mutant in examples), in particular when stored for 3 or more days, 4 or more days, 7 or more Days, 10 or more days, 12 or more days, 14 or more days, 21 or more days or 28 or more days can have an increased stability in detergents or cleaning agents.
- the proteases according to the invention have enzymatic activity, that is to say they are capable of hydrolyzing peptides and proteins, in particular in a washing or cleaning agent.
- a protease according to the invention is therefore an enzyme which catalyzes the hydrolysis of amide / peptide bonds in protein / peptide substrates and is thereby able to cleave proteins or peptides.
- a protease according to the invention is preferably a mature protease, ie the catalytically active molecule without signal and / or propeptide (s). Unless stated otherwise, the specified sequences also relate to mature (processed) enzymes.
- the protease is a free enzyme. This means that the protease can act directly with all components of an agent and, if the agent is a liquid agent, that the protease is in direct contact with the agent's solvent (e.g. water).
- an agent can contain proteases that form an interaction complex with other molecules or that contain an “envelope”.
- a single or multiple protease molecules can be separated from the other components of the agent by a structure surrounding them.
- a separating structure can arise from, but is not limited to, vesicles such as a micelle or a liposome.
- the surrounding structure can also be a virus particle, a bacterial cell or a eukaryotic cell.
- an agent can contain cells from Bacillus pumilus or Bacillus subtilus which express the proteases according to the invention, or cell culture supernatants of such cells.
- the protease comprises an amino acid sequence which is at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77% of the total length of the amino acid sequence given in SEQ ID NO: 1 , 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5% , 98%, 98.5% and 98.8% is identical, and in each case, based on the numbering according to SEQ ID NO: 1, has the amino acid substitutions given above.
- a protease has the specified substitutions means that it contains one (of the specified) substitution (s) at the respective position, i.e. at least the positions indicated are not otherwise mutated or deleted, for example by fragmentation of the protease.
- sequence comparison is based on the BLAST algorithm that is established and commonly used in the prior art (cf., for example, Altschul, SF, Gish, W., Miller, W., Myers, EW & Lipman, DJ (1990) "Basic local alignment search tool . "J. Mol. Biol. 215: 403-410, and Altschul, Stephan F., Thomas L. Madden, Alejandro A. Schaffer, Jinghui Zhang, Hheng Zhang, Webb Miller, and David J.
- Gapped BLAST and PSI-BLAST a new generation of protein database search programs "; Nucleic Acids Res., 25, S.3389-3402) and occurs principally in that similar sequences of nucleotides or amino acids in the nucleic acid or amino acid sequences are assigned to one another. A tabular assignment of the relevant positions is made Another algorithm available in the prior art is the FASTA algorithm. Sequence comparisons (alignments), in particular multiple sequence comparisons, are created with computer programs. The Clustal series, for example, is often used (cf. for example Chenna et al. (2003 ): Multiple sequence alignment with the Clustal series of programs.
- T-Coffee see, for example, Notredame et al. (2000): T-Coffee: A novel method for multiple sequence alignments. J . Mol. Biol. 302, 205-217) or programs based on these programs or algorithms. Sequence comparisons are also possible (Alignments) with the computer program Vector NTI® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the specified standard parameters, whose AlignX module for the sequence comparisons is based on ClustalW. Unless otherwise stated, the sequence identity given herein is determined using the BLAST algorithm.
- Such a comparison also allows a statement about the similarity of the compared sequences to one another. It is usually given in percent identity, that is to say the proportion of identical nucleotides or amino acid residues in the same positions or in positions corresponding to one another in an alignment.
- the broader term of homology includes conserved amino acid exchanges in the case of amino acid sequences, i.e. amino acids with similar chemical activity, since these usually exert similar chemical activities within the protein. Therefore, the similarity of the compared sequences can also be given as percent homology or percent similarity. Identity and / or homology information can be made over entire polypeptides or genes or only over individual areas. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by matches in the sequences.
- Such areas often have identical functions. They can be small and only contain a few nucleotides or amino acids. Such small areas often have essential functions for the overall activity of the protein. It can therefore be useful to relate sequence matches only to individual, possibly small areas. Unless otherwise stated, the identity or homology information in the present application relates to the total length of the nucleic acid or amino acid sequence specified in each case.
- the statement that an amino acid position corresponds to a numerically designated position in SEQ ID NO: 1 means that the corresponding position is assigned to the numerically designated position in SEQ ID NO: 1 in an alignment as defined above.
- the protease is characterized in that its cleaning performance (after storage, for example over 4 weeks) is not significant compared to that of a protease which is characterized as mutant 1 in the examples of the present invention and has the correspondingly marked amino acid substitutions is reduced, ie has at least 80% of the reference washing performance, preferably at least 100%, more preferably at least 110% or more.
- the cleaning performance can be determined in a washing system that contains a detergent in a dosage between 4.5 and 7.0 grams per liter of washing liquor as well as the protease, with the proteases to be compared being used in the same concentration (based on active protein) and the cleaning performance opposite Soiling on cotton is determined by measuring the degree of cleaning of the washed textiles.
- the washing process can take place for 60 minutes at a temperature of 40 ° C and the water has a water hardness between 15.5 and 16.5 ° (German hardness).
- the concentration of the protease in the detergent intended for this washing system is 0.001-0.1% by weight, preferably 0.01 to 0.06% by weight, based on active, purified protein.
- a liquid reference detergent for such a washing system can be composed as follows (all data in percent by weight): 4.4% alkylbenzenesulfonic acid, 5.6% other anionic surfactants, 2.4% C12-C18 Na salts of fatty acids (soaps) , 4.4% non-ionic surfactants, 0.2% phosphonates, 1.4% citric acid, 0.95% NaOH, 0.01% defoamer, 2% glycerine, 0.08% preservatives, 1% ethanol, the remainder demineralized Water.
- the dosage of the liquid detergent is preferably between 4.5 and 6.0 grams per liter of wash liquor, for example 4.7, 4.9 or 5.9 grams per liter of wash liquor. Washing is preferably carried out in a pH range between pH 7 and pH 10.5, preferably between pH 7.5 and pH 8.5.
- the cleaning performance is determined, for example, at 20 ° C. or 40 ° C. using a liquid detergent as indicated above, the washing process preferably taking place for 60 minutes at 600 rpm.
- the whiteness i.e. the lightening of the soiling, as a measure of the cleaning performance, is determined using optical measuring methods, preferably photometrically.
- a suitable device for this is, for example, the Minolta CM508d spectrometer.
- the devices used for the measurement are usually calibrated beforehand with a white standard, preferably a supplied white standard.
- the respective protease By using the respective protease with the same activity, it is ensured that the respective enzymatic properties, e.g. the cleaning performance on certain soiling, are compared even if the ratio of active substance to total protein (the values of the specific activity) diverges. As a general rule, a low specific activity can be compensated for by adding a larger amount of protein.
- the protease activity can be determined via the release of the chromophore para-nitroaniline (pNA) from the substrate suc-L-Ala-L-Ala-L-Pro-L-Phe-p-nitroanilide (AAPF).
- pNA chromophore para-nitroaniline
- the protease cleaves the substrate and releases pNA.
- the release of the pNA causes an increase in the extinction at 410 nm, the course of which over time is a measure of the enzymatic activity (cf. Del Mar et al., 1979).
- the measurement takes place at a temperature of 25 ° C., at pH 8.6, and a wavelength of 410 nm.
- the measurement time is 5 minutes and the measurement interval is 20s to 60s.
- the protease activity is usually given in protease units (PU). Suitable protease activities are, for example, 2.25, 5 or 10 PU per ml of wash liquor. However, the protease activity is not zero.
- An alternative test for determining the proteolytic activity of the proteases according to the invention is an optical measuring method, preferably a photometric method.
- the test suitable for this comprises the protease-dependent cleavage of the substrate protein casein. This is split into a large number of smaller partial products by the protease. The totality of these partial products has an increased absorption at 290 nm compared to non-split casein, this increased absorption being determined using a photometer and thus a conclusion about the enzymatic activity of the protease can be drawn.
- the protein concentration can be determined using known methods, for example the BCA method (bicinchoninic acid; 2,2'-bichinolyl-4,4'-dicarboxylic acid) or the biuret method (AG Gornall, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766).
- the active protein concentration can be determined by titrating the active centers using a suitable irreversible inhibitor and determining the residual activity (cf. M. Bender et al., J. Am. Chem. Soc. 88, 24 (1966), p. 5890 -5913).
- proteases according to the invention can have further amino acid changes, in particular amino acid substitutions, insertions or deletions.
- Such proteases are further developed, for example, by targeted genetic modification, ie by mutagenesis processes, and optimized for specific purposes or with regard to special properties (for example with regard to their catalytic activity, stability, etc.).
- nucleic acids according to the invention can be introduced into recombination batches and thus used to generate completely new proteases or other polypeptides. The aim is to introduce specific mutations such as substitutions, insertions or deletions into the known molecules in order, for example, to improve the cleaning performance of enzymes according to the invention.
- the surface charges and / or the isoelectric point of the molecules and thereby their interactions with the substrate can be changed.
- the net charge of the enzymes can be changed in order to influence the substrate binding, especially for use in detergents and cleaning agents.
- one or more corresponding mutations can increase the stability or catalytic activity of the protease and thereby improve its cleaning performance.
- Advantageous properties of individual mutations, for example individual substitutions, can complement one another.
- a protease that has already been optimized with regard to certain properties, for example with regard to its stability during storage, can therefore be further developed within the scope of the invention.
- amino acid substitutions first the naturally present amino acid is designated in the form of the internationally common single-letter code, then the associated sequence position and finally the inserted amino acid. Multiple exchanges within the same polypeptide chain are separated from one another by slashes. In the case of insertions, additional amino acids are named after the sequence position. In the case of deletions, the missing amino acid is replaced by a symbol, for example an asterisk or a dash, or a D is given in front of the corresponding position.
- P9T describes the substitution of proline at position 9 by threonine
- P9TH the insertion of histidine after the amino acid threonine at position 9
- P9 * or DR9 the deletion of proline at position 9.
- the invention therefore also provides a protease which is characterized in that it can be obtained from a protease as described above as the starting molecule by single or multiple conservative amino acid substitutions, the protease being those described above in the number according to SEQ ID NO: 1 Has amino acid substitutions.
- conservative amino acid substitution means the exchange (substitution) of an amino acid residue for another amino acid residue, this exchange not leading to a change in polarity or charge at the position of the exchanged amino acid, e.g. B. the exchange of a non-polar amino acid residue for another non-polar amino acid residue.
- the protease is characterized in that it can be obtained from a protease according to the invention as a starting molecule by fragmentation, deletion, insertion or substitution mutagenesis and comprises an amino acid sequence which has a Length of at least 200, 210, 220, 230, 240, 250, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273 or 274 contiguous amino acids with the starting molecule , where the amino acid substitutions described above, ie the substitutions 9T, 133A, 144K, 252T and 271 E or the substitutions at the positions corresponding to positions 3, 4, 82, 156, 162 and / or 218 and optionally 130, still available.
- the proteases described herein are modified, the modification takes place in such a way that the substitutions according to the invention are retained.
- the enzymes retain their proteolytic activity even after the mutagenesis, i. E. their proteolytic activity corresponds at least to that of the parent enzyme, i.e. In a preferred embodiment, the proteolytic activity is at least 80, preferably at least 90% of the activity of the starting enzyme. Further substitutions can also have advantageous effects. Both single and several connected amino acids can be exchanged for other amino acids.
- the other amino acid positions are defined by an alignment of the amino acid sequence of a protease according to the invention with the amino acid sequence of the protease from Bacillus pumilus, as indicated in SEQ ID NO: 1. Furthermore, the allocation of the positions is based on the mature (mature) protein. This assignment is also to be used in particular if the amino acid sequence of a protease according to the invention comprises a higher number of amino acid residues than the protease from Bacillus pumilus according to SEQ ID NO: 1. Starting from the positions mentioned in the amino acid sequence of the protease from Bacillus pumilus, the change positions in a protease according to the invention are those which are assigned to these positions in an alignment.
- Advantageous positions for sequence changes, in particular substitutions, of the protease from Bacillus pumilus which are preferably of importance when transferred to homologous positions of the proteases according to the invention and give the protease advantageous functional properties, are accordingly the positions which correspond to the positions described herein in an alignment, i.e. in the count according to SEQ ID NO: 1.
- the following amino acid residues are located in the wild-type molecule of the protease from Bacillus pumilus at the positions mentioned: T3, V4, P9, L82, N130, T133, N144, S156, T162, T218, N252 and Q271.
- an amino acid exchange in a certain position of the protease from Bacillus pumilus according to SEQ ID NO: 1 is accompanied by a change in an enzymatic parameter, for example with an increase in the K M value, and a corresponding change in the enzymatic parameter, for example also a
- An increase in the K M value observed in a protease variant according to the invention, the amino acid exchange of which was achieved by the same introduced amino acid, is a confirmation of the correct assignment.
- the protease or the protease produced using a method according to the invention is still at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80 %, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92, 5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5% , or 98.8% identical to the amino acid sequence given in SEQ ID NO: 1 over its entire length.
- the protease or the protease produced by a method according to the invention has the amino acid substitutions selected from 9T, 133A, 144K, 252T and 271 E at the positions which correspond to positions 9, 133, 144, 252 and 271; as well as at least one amino acid substitution at least one of the positions which correspond to positions 3, 4, 82, 156, 162 and 218, each based on the numbering according to SEQ ID NO: 1.
- the invention relates to proteases according to SEQ ID NO: 1 with the following amino acid substitution variants:
- the invention also relates to a protease described above which is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer.
- An increase in the stability during storage and / or during use, for example during the washing process, means that the enzymatic activity lasts longer and thus the cleaning performance is improved.
- all stabilization options described and / or expedient in the prior art come into consideration. Stabilizations that are achieved via mutations of the enzyme itself are preferred, since such stabilizations do not require any further work steps following the recovery of the enzyme. Examples of sequence changes suitable for this are mentioned above. Further suitable sequence changes are known from the prior art.
- Changing the binding of metal ions, in particular the calcium binding sites for example by replacing one or more of the amino acid (s) involved in calcium binding with one or more negatively charged amino acids and / or by introducing sequence changes in at least one of the consequences of the two amino acids arginine / glycine;
- Preferred embodiments are those in which the enzyme is stabilized in several ways, since several stabilizing mutations act additively or synergistically.
- Another object of the invention is a protease as described above, which is characterized in that it has at least one chemical modification.
- a protease with such a change is called a derivative, i. the protease is derivatized.
- derivatives are accordingly understood to mean those proteins whose pure amino acid chain has been chemically modified.
- derivatizations can take place, for example, in vivo by the host cell expressing the protein.
- couplings of low molecular weight compounds such as lipids or oligosaccharides should be particularly emphasized.
- derivatizations can also be carried out in vitro, for example by chemically converting a side chain of an amino acid or by covalently binding another compound to the protein.
- Such a different compound can also be a further protein which is bound to a protein according to the invention, for example via bifunctional chemical compounds.
- derivatization is to be understood as the covalent bond to a macromolecular carrier, or also a non-covalent inclusion in suitable macromolecular cage structures.
- Derivatizations can, for example, influence the substrate specificity or the strength of the binding to the substrate or bring about a temporary blocking of the enzymatic activity if the coupled substance is an inhibitor. This can be useful for the period of storage, for example.
- Such modifications can also affect the stability or the enzymatic activity. They can also serve to reduce the allergenicity and / or immunogenicity of the protein and thus, for example, to increase its skin tolerance.
- couplings with macromolecular compounds for example polyethylene glycol, can improve the protein in terms of stability and / or skin tolerance.
- derivatives of a protein according to the invention can also be understood to mean preparations of these proteins.
- a protein can be combined with various other substances, for example from the culture of the producing microorganisms.
- a protein can also have been deliberately mixed with other substances, for example to increase its storage stability. All preparations of a protein according to the invention are therefore also in accordance with the invention. This is also independent of whether it actually displays this enzymatic activity in a particular preparation or not. This is because it may be desirable for it to have little or no activity during storage and only develop its enzymatic function at the time of use. This can be controlled, for example, via corresponding accompanying substances.
- the joint preparation of proteases with specific inhibitors is possible in this regard.
- the invention furthermore relates to a nucleic acid which codes for a protease according to the invention, and a vector containing such a nucleic acid, in particular a cloning vector or an expression vector.
- RNA molecules can be DNA or RNA molecules. They can be present as a single strand, as a single strand complementary to this single strand, or as a double strand. In the case of DNA molecules in particular, the sequences of both complementary strands must be taken into account in all three possible reading frames. It should also be taken into account that different codons, that is to say base triplets, can code for the same amino acids, so that a certain amino acid sequence can be coded by several different nucleic acids. Because of this degeneracy of the genetic code, all nucleic acid sequences are included in this subject matter of the invention which can code for one of the proteases described above.
- nucleic acid sequences unequivocally since, despite the degeneracy of the genetic code, defined amino acids have to be assigned to individual codons.
- the person skilled in the art can therefore easily determine nucleic acids coding for this amino acid sequence on the basis of an amino acid sequence.
- one or more codons in the nucleic acids according to the invention can be replaced by synonymous codons.
- This aspect relates in particular to the heterologous expression of the enzymes according to the invention. Every organism, for example a host cell of a production strain, has a specific codon usage. Codon usage means the translation of the genetic code into amino acids by the respective organism.
- Bottlenecks in protein biosynthesis can arise if the codons on the nucleic acid are compared to a comparatively small number of loaded tRNA molecules in the organism. Although coding for the same amino acid, this means that a codon is translated less efficiently in the organism than a synonymous codon which codes for the same amino acid. Due to the presence of a higher number of tRNA molecules for the synonymous codon, this can be translated more efficiently in the organism.
- a person skilled in the art is able to use known DNA and / or amino acid sequences to identify the corresponding nucleic acids up to complete genes using known DNA and / or amino acid sequences, for example chemical synthesis or the polymerase chain reaction (PCR) in conjunction with standard molecular biological and / or protein chemical methods to manufacture.
- PCR polymerase chain reaction
- Such methods are for example from Sambrook, J., Fritsch, EF and Maniatis, T. 2001. Molecular cloning: a laboratory manual, 3rd Edition Cold Spring Laboratory Press.
- vectors are understood to mean elements consisting of nucleic acids which contain a nucleic acid according to the invention as the characterizing nucleic acid region. They are able to establish this as a stable genetic element in a species or a cell line over several generations or cell divisions.
- Vectors are special plasmids, i.e. circular genetic elements, especially when used in bacteria.
- a nucleic acid according to the invention is cloned into a vector.
- the vectors include, for example, those whose origin is bacterial plasmids, viruses or bacteriophages, or predominantly synthetic vectors or plasmids with elements of various origins. With the other genetic elements present in each case, vectors are able to establish themselves as stable units in the host cells concerned over several generations. They can exist extrachromosomally as separate units or integrate into a chromosome or chromosomal DNA.
- Expression vectors comprise nucleic acid sequences which enable them to replicate in the host cells containing them, preferably microorganisms, particularly preferably bacteria, and to express a nucleic acid contained there.
- the expression is influenced in particular by the promoter or promoters that regulate transcription.
- expression can take place through the natural promoter originally located in front of the nucleic acid to be expressed, but also through a host cell promoter provided on the expression vector or also through a modified or completely different promoter from another organism or another host cell.
- at least one promoter for the expression of a nucleic acid according to the invention is made available and used for its expression.
- Expression vectors can also be regulatable, for example by changing the cultivation conditions or when the host cells they contain reach a certain cell density or by adding certain substances, in particular activators of gene expression.
- An example of such a substance is the galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside (IPTG), which is used as an activator of the bacterial lactose operon (lac operon).
- IPTG galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside
- lac operon lactose operon
- the invention also relates to a non-human host cell which contains a nucleic acid according to the invention or a vector according to the invention, or which contains a protease according to the invention, in particular one which secretes the protease into the medium surrounding the host cell.
- a nucleic acid according to the invention or a vector according to the invention is preferably transformed into a microorganism which then represents a host cell according to the invention.
- individual components, ie nucleic acid parts or fragments of a nucleic acid according to the invention can also be incorporated into a Host cell are introduced so that the host cell then resulting contains a nucleic acid according to the invention or a vector according to the invention.
- This procedure is particularly suitable when the host cell already contains one or more components of a nucleic acid according to the invention or a vector according to the invention and the further components are then supplemented accordingly.
- Methods for transforming cells are established in the prior art and are sufficiently known to the person skilled in the art. In principle, all cells, that is, prokaryotic or eukaryotic cells, are suitable as host cells. Preference is given to those host cells which can be manipulated in a genetically advantageous manner, for example with regard to the transformation with the nucleic acid or the vector and its stable establishment, for example unicellular fungi or bacteria. Furthermore, preferred host cells are characterized by good microbiological and biotechnological manageability.
- Preferred host cells according to the invention secrete the (transgenically) expressed protein into the medium surrounding the host cells.
- the proteases can be modified by the cells producing them after they have been produced, for example by attaching sugar molecules, formylations, aminations, etc. Such post-translational modifications can functionally influence the protease.
- Further preferred embodiments are those host cells whose activity can be regulated on the basis of genetic regulatory elements, which are provided, for example, on the vector, but can also be present in these cells from the outset. For example, through the controlled addition of chemical compounds that serve as activators, by changing the cultivation conditions or when a certain cell density is reached, these can be stimulated to express. This enables the proteins according to the invention to be produced economically.
- An example of such a connection is IPTG as described above.
- Preferred host cells are prokaryotic or bacterial cells.
- Bacteria are characterized by short generation times and low demands on the cultivation conditions. In this way, inexpensive cultivation processes or manufacturing processes can be established.
- the specialist in bacteria in fermentation technology has a wealth of experience.
- Gram-negative or gram-positive bacteria may be suitable for a special production for a wide variety of reasons, to be determined experimentally in individual cases, such as nutrient sources, product formation rate, time required, etc.
- Gram-negative bacteria such as Escherichia coli
- a large number of proteins are secreted into the periplasmic space, i.e. into the compartment between the two membranes enclosing the cells.
- gram-negative bacteria can also be designed in such a way that they contain the expressed proteins not only into the periplasmic space, but into the medium surrounding the bacterium.
- Gram-positive bacteria such as Bacilli or Actinomycetes or other representatives of the Actinomycetales, on the other hand, have no outer membrane, so that secreted proteins are immediately released into the medium surrounding the bacteria, usually the nutrient medium, from which the expressed proteins can be purified. They can be isolated directly from the medium or processed further.
- Gram-positive bacteria are related or identical to most of the original organisms for technically important enzymes and usually form comparable enzymes themselves, so that they have a similar codon usage and their protein synthesis apparatus is naturally designed accordingly.
- Host cells according to the invention can be changed with regard to their requirements for the culture conditions, have different or additional selection markers or also express other or additional proteins.
- these host cells can also be those which transgenically express several proteins or enzymes.
- the present invention is in principle applicable to all microorganisms, in particular to all fermentable microorganisms, particularly preferably to those of the genus Bacillus, and leads to the fact that proteins according to the invention can be produced by using such microorganisms. Such microorganisms then represent host cells within the meaning of the invention.
- the host cell is characterized in that it is a bacterium, preferably one selected from the group of the genera Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacterium, Arthrobacter, Streptomyces, Stenotrophomonas and Pseudomonas, more preferably one which is selected from the group of Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus lentus, Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus alcalophilus, Bacillus globigii, Bacillus gibsonii, Bacillus clausumum, Bacillus carnilus pacilocumlocus, Bacillus carnaphumlocumlocyans, Bacillus carnodurans , Arthrobacter oxidans, Streptomyces lividans, Streptomyces coeli
- a bacterium
- the host cell can also be a eukaryotic cell, which is characterized in that it has a cell nucleus.
- the invention therefore also provides a host cell which is characterized in that it has a cell nucleus.
- eukaryotic cells are able to post-translationally modify the protein formed. Examples are fungi such as Actinomycetes or yeasts such as Saccharomyces or Kluyveromyces. This can be particularly advantageous, for example, if the proteins are to undergo specific modifications in connection with their synthesis, which make such systems possible.
- the eukaryotic systems perform especially in connection with protein synthesis, include, for example, the binding of low molecular weight compounds such as membrane anchors or oligosaccharides.
- oligosaccharide modifications can be desirable, for example, to reduce the allergenicity of an expressed protein.
- Coexpression with the enzymes naturally formed by such cells, such as cellulases, can also be advantageous.
- thermophilic fungal expression systems can be particularly suitable for expressing temperature-resistant proteins or variants.
- the host cells according to the invention are cultivated and fermented in the usual way, for example in discontinuous or continuous systems.
- a suitable nutrient medium is inoculated with the host cells and the product is harvested from the medium after a period to be determined experimentally.
- Continuous fermentations are characterized by the achievement of a steady state in which cells partially die off over a comparatively long period of time, but also grow back and at the same time the protein formed can be removed from the medium.
- Host cells according to the invention are preferably used to produce proteases according to the invention.
- the invention therefore also relates to a method for producing a protease
- This subject matter of the invention preferably comprises fermentation processes. Fermentation processes are known per se from the prior art and represent the actual large-scale production step, usually followed by a suitable purification method for the product produced, for example the proteases according to the invention. All fermentation processes that are based on a corresponding process for the production of a protease according to the invention represent embodiments of this subject matter of the invention.
- Fermentation processes which are characterized in that the fermentation is carried out using a feed strategy are particularly suitable.
- the media components that are consumed by the continuous cultivation are fed in here. In this way, considerable increases can be achieved both in the cell density and in the cell mass or dry mass and / or in particular in the activity of the protease of interest.
- the fermentation can also be designed in such a way that undesired metabolic products are filtered out or neutralized by adding buffer or suitable counterions.
- the protease produced can be harvested from the fermentation medium.
- Such a fermentation process is opposite to an isolation of the protease from the host cell, ie one Product preparation from the cell mass (dry matter) preferred, but requires the provision of suitable host cells or one or more suitable secretion markers or mechanisms and / or transport systems so that the host cells secrete the protease into the fermentation medium.
- the protease can alternatively be isolated from the host cell, ie it can be purified from the cell mass, for example by precipitation with ammonium sulfate or ethanol, or by chromatographic purification.
- the invention also relates to an agent which is characterized in that it contains a protease according to the invention as described above.
- the agent is preferred as a washing or cleaning agent.
- washing or cleaning agent both concentrates and agents to be used undiluted, for use on a commercial scale, in the washing machine or for hand washing or cleaning.
- detergents for textiles, carpets, or natural fibers, for which the term detergent is used.
- dishwashing detergents for dishwashers or manual dishwashing detergents or cleaners for hard surfaces such as metal, glass, porcelain, ceramics, tiles, stone, painted surfaces, plastics, wood or leather, for which the term detergent is used, i.e. in addition to manual and mechanical Dishwashing detergents, for example, also scouring agents, glass cleaners, toilet scented rinsing agents, etc.
- the detergents and cleaning agents within the scope of the invention also include washing aids that are added to the actual washing agent during manual or machine laundry to achieve a further effect.
- laundry detergents and cleaning agents in the context of the invention also include textile pretreatment and aftertreatment agents, i.e. those agents with which the item of laundry is brought into contact before the actual laundry, for example to loosen stubborn dirt, and also those agents that are in one of the actual Textile washing, the subsequent step, give the laundry further desirable properties such as a pleasant feel, crease resistance or low static charge.
- the latter means include the fabric softener.
- the detergents or cleaning agents according to the invention which can be present as pulverulent solids, in compacted particle form, as homogeneous solutions or suspensions, can contain, in addition to a protease according to the invention, all known ingredients that are customary in such agents, at least one further ingredient preferably being present in the agent .
- the agents according to the invention can in particular contain surfactants, builders, peroxygen compounds or bleach activators. They can also be water-miscible contain organic solvents, further enzymes, sequestering agents, electrolytes, pH regulators and / or further auxiliaries such as optical brighteners, graying inhibitors, foam regulators and dyes and fragrances and combinations thereof.
- a combination of a protease according to the invention with one or more further ingredient (s) of the agent is advantageous, since such an agent in preferred embodiments according to the invention has an improved cleaning performance due to the resulting synergisms.
- Such a synergism can be achieved in particular through the combination of a protease according to the invention with a surfactant and / or a builder (builder) and / or a peroxygen compound and / or a bleach activator.
- the agent according to the invention cannot contain any boric acid.
- An agent according to the invention advantageously contains the protease in an amount of 2 pg to 20 mg, preferably 5 pg to 17.5 mg, particularly preferably 20 pg to 15 mg and very particularly preferably 50 pg to 10 mg per g of the agent.
- the concentration of the protease (active enzyme) described herein in the agent is> 0 to 1% by weight, preferably 0.001 to 0.1% by weight, based on the total weight of the agent or the composition.
- the protease contained in the agent and / or other ingredients of the agent can be coated with a substance which is impermeable to the enzyme at room temperature or in the absence of water and which becomes permeable to the enzyme under conditions of use of the agent.
- Such an embodiment of the invention is thus characterized in that the protease is coated with a substance which is impermeable to the protease at room temperature or in the absence of water.
- the washing or cleaning agent itself can be packaged in a container, preferably an air-permeable container, from which it is released shortly before use or during the washing process.
- the agent is characterized in that it
- (a) is in solid form, in particular as a free-flowing powder with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l, or
- (b) is present in pasty or liquid form, and / or
- (e) is divided into several components.
- These embodiments of the present invention include all solid, powdery, liquid, gel-like or pasty dosage forms of agents according to the invention, which can optionally also consist of several phases and can be in compressed or uncompressed form.
- the agent can be in the form of a free-flowing powder, in particular with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l or 600 g / l to 850 g / l.
- the solid dosage forms of the agent also include extrudates, granules, tablets or pouches.
- the agent can also be liquid, gel-like or pasty, for example in the form of a non-aqueous liquid detergent or a non-aqueous paste or in the form of an aqueous liquid detergent or a water-containing paste. Liquid funds are generally preferred.
- the agent can be in the form of a one-component system. Such means consist of a phase. Alternatively, a remedy can also consist of several phases. Such a means is therefore divided into several components.
- Washing or cleaning agents according to the invention can exclusively contain a protease. Alternatively, they can also contain further hydrolytic enzymes or other enzymes in an appropriate concentration for the effectiveness of the agent. A further embodiment of the invention thus represent agents which also comprise one or more further enzymes.
- enzymes which can preferably be used are all enzymes which can develop a catalytic activity in the agent according to the invention, in particular a lipase, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, xyloglucanase, ⁇ -glucosidase, pectinase, carrageenase, perhydrolase, Oxidase, oxidoreductase or other proteases - distinguishable from the proteases according to the invention - and mixtures thereof.
- each additional enzyme is in an amount of 1 x 10- 7 -3 wt .-%, of 0.00001-1 wt .-%, of from 0.00005 to 0.5 wt .-%, from 0.0001 up to 0.1% by weight and particularly preferably from 0.0001 to 0.05% by weight in agents according to the invention, based on active protein.
- the enzymes particularly preferably show synergistic cleaning performance with respect to specific soiling or stains, ie the enzymes contained in the agent composition mutually support one another in their cleaning performance.
- Such a synergism is particularly preferably present between the protease contained according to the invention and a further enzyme of an agent according to the invention, including in particular between said protease and an amylase and / or a lipase and / or a mannanase and / or a cellulase and / or a pectinase .
- Synergistic effects can occur not only between different enzymes, but also between one or more enzymes and other ingredients of the agent according to the invention.
- the enzymes to be used can also be packaged together with accompanying substances, for example from fermentation.
- the enzymes are preferably used as liquid enzyme formulation (s).
- the enzymes are not made available in the form of the pure protein, but rather in the form of stabilized, storable and transportable preparations.
- These prefabricated preparations include, for example, the solid preparations obtained by granulation, extrusion or lyophilization or, in particular in the case of liquid or gel-like agents, solutions of the enzymes, advantageously as concentrated as possible, with little water and / or with stabilizers or other auxiliaries.
- the enzymes can be encapsulated both for the solid and for the liquid dosage form, for example by spray drying or extrusion of the enzyme solution together with a preferably natural polymer or in the form of capsules, for example those in which the enzymes are enclosed as in a solidified gel or those of the core-shell type, in which an enzyme-containing core is coated with a protective layer impermeable to water, air and / or chemicals.
- Additional active ingredients for example stabilizers, emulsifiers, pigments, bleaches or dyes, can also be applied in superimposed layers.
- Such capsules are applied according to methods known per se, for example by pouring or rolling granulation or in fluid-bed processes. Such granules are advantageously low in dust, for example due to the application of polymeric film formers, and due to the coating are stable in storage.
- water-soluble films such as those used, for example, in the formulation of detergents and cleaning agents in unit dose form.
- Such a film enables the enzymes to be released after contact with water.
- water soluble refers to a film structure that is preferably completely water soluble.
- Such a film preferably consists of (completely or partially hydrolyzed) polyvinyl alcohol (PVA).
- Another subject matter of the invention is a method for cleaning textiles or hard surfaces, which is characterized in that an agent according to the invention is used in at least one method step, or that a protease according to the invention becomes catalytically active in at least one method step, in particular such that the protease in an amount of 40 pg to 4 g, preferably 50 pg to 3 g, particularly preferably 100 pg to 2 g and very particularly preferably 200 pg to 1 g or the concentrations described herein.
- the method described above is characterized in that the protease is used at a temperature of 0-100 ° C, preferably 0-60 ° C, more preferably 20-40 ° C and most preferably at 25 ° C.
- Processes for cleaning textiles are generally characterized by the fact that various active cleaning substances are applied to the items to be cleaned in several process steps and washed off after the exposure time, or that the items to be cleaned are treated in some other way with a detergent or a solution or dilution of this agent.
- All conceivable washing or cleaning processes can be enriched in at least one of the process steps by the use of a washing or cleaning agent according to the invention or a protease according to the invention and then represent embodiments of the present invention
- Means are described are also applicable to this subject matter of the invention. Therefore, reference is expressly made at this point to the disclosure at the appropriate point with the note that this disclosure also applies to the above methods according to the invention.
- proteases according to the invention already naturally have a hydrolytic activity and also develop this in media that otherwise have no cleaning power, such as, for example, in mere buffers, a single and / or the only step of such a process can consist in the fact that the only active cleaning component is a protease according to the invention is brought into contact with the soil, preferably in a buffer solution or in water. This represents a further embodiment of this subject matter of the invention.
- Alternative embodiments of this subject matter of the invention also represent processes for treating raw textile materials or for textile care, in which a protease according to the invention becomes active in at least one process step.
- processes for textile raw materials, fibers or textiles with natural components are preferred, and very particularly for those with wool or silk.
- the invention also includes the use of the proteases described herein in washing or cleaning agents, for example as described above, for the (improved) removal of protein-containing soiling, for example from textiles or hard surfaces.
- the protease is in the washing or cleaning agent before a washing or cleaning process 3 or more days, 4 or more days, 7 or more days, 10 or more days, 12 or more days, 14 or more days, 21 or more Stored for days or 28 days or more.
- the activity of the protease is determined by the release of the chromophore para-nitroaniline from the substrate succinyl alanine-alanine-proline-phenylalanine-para-nitroanilide (AAPFpNA; Bachem L-1400).
- AAPFpNA succinyl alanine-alanine-proline-phenylalanine-para-nitroanilide
- the measurement was carried out at a temperature of 25 ° C., at pH 8.6 and a wavelength of 410 nm.
- the measurement time was 5 minutes with a measurement interval of 20 to 60 seconds.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Detergent Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102019111075.0A DE102019111075A1 (de) | 2019-04-29 | 2019-04-29 | Verbesserte Reinigungsleistung gegenüber Protein-empfindlichen Anschmutzungen VI |
PCT/EP2020/060375 WO2020221578A1 (de) | 2019-04-29 | 2020-04-14 | Verbesserte reinigungsleistung gegenüber protein-empfindlichen anschmutzungen vi |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3963064A1 true EP3963064A1 (de) | 2022-03-09 |
Family
ID=70289777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20719389.7A Pending EP3963064A1 (de) | 2019-04-29 | 2020-04-14 | Verbesserte reinigungsleistung gegenüber protein-empfindlichen anschmutzungen vi |
Country Status (4)
Country | Link |
---|---|
US (1) | US20220064621A1 (de) |
EP (1) | EP3963064A1 (de) |
DE (1) | DE102019111075A1 (de) |
WO (1) | WO2020221578A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023225459A2 (en) | 2022-05-14 | 2023-11-23 | Novozymes A/S | Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections |
CN116615536A (zh) | 2021-03-15 | 2023-08-18 | 宝洁公司 | 含有多肽变体的清洁组合物 |
EP4108767A1 (de) | 2021-06-22 | 2022-12-28 | The Procter & Gamble Company | Reinigungs- oder behandlungszusammensetzungen mit nuklease-enzymen |
CA3238546A1 (en) | 2021-12-16 | 2023-06-22 | Katarzyna Dorota BELL-RUSIEWICZ | Home care composition comprising an amylase |
US20230272310A1 (en) | 2021-12-16 | 2023-08-31 | The Procter & Gamble Company | Home care composition |
CA3240641A1 (en) | 2021-12-16 | 2023-06-22 | Michelle Jackson | Automatic dishwashing composition comprising a protease |
US20230365897A1 (en) | 2021-12-16 | 2023-11-16 | The Procter & Gamble Company | Fabric and home care composition including a protease |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
WO2024163695A1 (en) | 2023-02-01 | 2024-08-08 | The Procter & Gamble Company | Detergent compositions containing enzymes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006022224A1 (de) | 2006-05-11 | 2007-11-15 | Henkel Kgaa | Subtilisin aus Bacillus pumilus und Wasch- und Reinigungsmittel enthaltend dieses neue Subtilisin |
DE102008017103A1 (de) | 2008-04-02 | 2009-10-08 | Henkel Ag & Co. Kgaa | Wasch- und Reinigungsmittel enthaltend Proteasen aus Xanthomonas |
DE102016208463A1 (de) * | 2016-05-18 | 2017-11-23 | Henkel Ag & Co. Kgaa | Leistungsverbesserte Proteasen |
WO2019048495A1 (de) * | 2017-09-05 | 2019-03-14 | Henkel Ag & Co. Kgaa | Leistungsverbesserte proteasevarianten i |
-
2019
- 2019-04-29 DE DE102019111075.0A patent/DE102019111075A1/de not_active Withdrawn
-
2020
- 2020-04-14 US US17/607,037 patent/US20220064621A1/en active Pending
- 2020-04-14 WO PCT/EP2020/060375 patent/WO2020221578A1/de unknown
- 2020-04-14 EP EP20719389.7A patent/EP3963064A1/de active Pending
Also Published As
Publication number | Publication date |
---|---|
DE102019111075A1 (de) | 2020-10-29 |
WO2020221578A1 (de) | 2020-11-05 |
US20220064621A1 (en) | 2022-03-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2021175697A1 (de) | Leistungsverbesserte proteasevarianten vii | |
EP4114934A1 (de) | Stabilitätsverbesserte proteasevarianten vi | |
EP3660151B1 (de) | Leistungsverbesserte und lagerstabile protease-varianten | |
EP3963065A1 (de) | Proteasen mit verbesserter enzymstabilität in wasch- und reinigungsmitteln iii | |
EP3963064A1 (de) | Verbesserte reinigungsleistung gegenüber protein-empfindlichen anschmutzungen vi | |
EP3679131B1 (de) | Leistungsverbesserte proteasevarianten ii | |
EP3963066A1 (de) | Verbesserte reinigungsleistung gegenüber protein-empfindlichen anschmutzungen v | |
EP3679133A1 (de) | Leistungsverbesserte proteasevarianten i | |
EP3679132B1 (de) | Leistungsverbesserte proteasevarianten iii | |
EP3660146B1 (de) | Leistungsverbesserte und lagerstabile protease-varianten | |
EP3433360B1 (de) | Proteasen mit verbesserte enzymstabilität in waschmittel | |
EP3458583B1 (de) | Leistungsverbesserte proteasen | |
EP3433359B1 (de) | Verbesserte reinigungsleistung an protein sensitiven anschmutzungen | |
DE102018004207A1 (de) | Leistungsverbesserte Varianten der alkalischen Protease aus B. lentus | |
DE102018208778A1 (de) | Leistungsverbesserte Proteasevarianten IV | |
DE102017215628A1 (de) | Leistungsverbesserte Proteasevarianten I | |
EP3440203B1 (de) | Neue protease mit verbesserter waschleistung | |
DE102021207704A1 (de) | Leistungsverbesserte Proteasevarianten VIII | |
DE102018208777A1 (de) | Leistungsverbesserte Proteasevarianten V | |
DE102017215631A1 (de) | Leistungsverbesserte Proteasevarianten II | |
EP3083955A1 (de) | Pilzliche proteasen und deren verwendung in wasch- und reinigungsmitteln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20211020 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230530 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20231213 |